Reported Earnings • 15h
Full year 2026 earnings released: CA$0.11 loss per share (vs CA$0.11 loss in FY 2025) Full year 2026 results: CA$0.11 loss per share (further deteriorated from CA$0.11 loss in FY 2025). Revenue: CA$26.7m (up 14% from FY 2025). Net loss: CA$13.5m (loss widened 34% from FY 2025). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 64% per year, which means it is tracking significantly ahead of earnings growth. New Risk • May 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$11m). Earnings have declined by 0.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (111% increase in shares outstanding). Minor Risk Share price has been volatile over the past 3 months (14% average weekly change). Announcement • Apr 25
PesoRama Inc. announced that it has received CAD 10.048501 million in funding On April 23, 2026, PesoRama Inc. has closed the transaction and issued 28,710,003 units at a price of CAF 0.35 per unit for aggregate gross proceeds of CAD10,048,501. The company also paid an aggregate of cash finders' fees of CAD 409,254, of which Canaccord Genuity Corp. was paid CAD 335,895 and Richardson Wealth Ltd. was paid CAD 73,359. The transaction is subject to final approval of the TSX Venture Exchange. Announcement • Apr 09
PesoRama Inc. announced that it expects to receive CAD 7 million in funding PesoRama Inc announced a non brokered private placement to issue 20,000,000 units at an issue price of CAD 0.35 for the proceeds of CAD 7,000,000 on April 8, 2026. Each Unit will be comprised of one common share and one half of one Common Share purchase warrant. Each Warrant will entitle the holder thereof to acquire one Common Share at a price of CAD 0.50 per Warrant Share for a period of 36 months from the Closing. Company may pay finder’s fees of up to 7% in cash to eligible finders in connection with the Private Placement. The Private Placement is expected to close on or about April 21, 2026 Closing of the Private Placement is subject to receipt of all necessary corporate and regulatory approvals, including the approval of TSXV. All securities issued in connection with the Private Placement will be subject to a hold period of four months plus a day from the date of issuance. Announcement • Mar 17
PesoRama Inc., Annual General Meeting, May 07, 2026 PesoRama Inc., Annual General Meeting, May 07, 2026. Announcement • Jan 27
PesoRama Inc., Annual General Meeting, Mar 17, 2026 PesoRama Inc., Annual General Meeting, Mar 17, 2026. Recent Insider Transactions • Jan 05
Board Member recently sold CA$53k worth of stock On the 30th of December, Sumesh Pathak sold around 160k shares on-market at roughly CA$0.33 per share. This transaction amounted to 6.3% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of CA$60k more than they bought in the last 12 months. Reported Earnings • Dec 19
Third quarter 2026 earnings released: CA$0.02 loss per share (vs CA$0.018 loss in 3Q 2025) Third quarter 2026 results: CA$0.02 loss per share (further deteriorated from CA$0.018 loss in 3Q 2025). Revenue: CA$6.70m (up 24% from 3Q 2025). Net loss: CA$2.82m (loss widened 59% from 3Q 2025). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has increased by 36% per year, which means it is tracking significantly ahead of earnings growth. New Risk • Dec 19
New major risk - Revenue and earnings growth Earnings have declined by 0.4% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$11m). Earnings have declined by 0.4% per year over the past 5 years. Shareholders have been substantially diluted in the past year (69% increase in shares outstanding). Minor Risk Market cap is less than US$100m (CA$44.5m market cap, or US$32.3m). Announcement • Nov 29
PesoRama Inc. announced that it has received CAD 5 million in funding On November 28, 2025, the company has closed the transaction. The company has issued 20,000,000 at a price of CAD 0.25 for gross proceeds of CAD 5,000,000. In connection with this closing, the company will pay a cash commission of up to CAD 105,000 and will issue up to 420,000 non-transferable finder warrants to arm's-length finders. Each finder warrant is exercisable into one unit at a price of CAD 0.25 at any time on or before May 29, 2027. The offering remains subject to final approval of the TSX-V. Announcement • Oct 21
PesoRama Inc. announced that it expects to receive CAD 5 million in funding PesoRama Inc. announced a LIFE offering to issue 14,000,000 units at an issue price of CAD 0.25 for gross proceeds of CAD 3,500,000 and a non-brokered private placement to issue 6,000,000 units at an issue price of CAD 0.25 for gross proceeds of CAD 1,500,000 for aggregate proceeds of CAD 5,000,000 on October 20, 2025. Each unit will consist of one common share of the company and one half of one common share purchase warrant with each warrant entitling the holder thereof to acquire one share at a price of CAD 0.40. Each warrant will be exercisable for a period of 18 months following the closing date. LIFE offering will be offered in all provinces of Canada except Québec and in the United States. Subject to the rules and policies of the TSXV, the securities issuable from the sale of units to Canadian resident subscribers will not be subject to a hold period under applicable Canadian securities laws. Insiders and certain consultants that participate in the LIFE offering would be subject to a four -month hold period in respect of securities issued pursuant to applicable policies of the TSXV. The units issued pursuant to the concurrent private placement may be offered to purchasers resident in Canada pursuant to applicable prospectus exemptions and may also be offered in the United States. Any securities issued under the concurrent private placement to purchasers resident in Canada will be subject to a hold period in accordance with applicable Canadian securities laws, expiring four months and one day following their date of issuance. It is expected that closing of the offering will take place on or about November 6, 2025 or such other date(s) as may be determined by the company. Closing of the offering is subject to certain conditions including, but not limited to, receipt of all necessary approvals, including the approval of the TSXV. It is anticipated that insiders of the company may participate in the offering, and such units issued to insiders will be subject to a four month hold period pursuant to applicable policies of the TSXV. Reported Earnings • Sep 25
Second quarter 2026 earnings released: CA$0.028 loss per share (vs CA$0.026 loss in 2Q 2025) Second quarter 2026 results: CA$0.028 loss per share (further deteriorated from CA$0.026 loss in 2Q 2025). Revenue: CA$6.10m (up 12% from 2Q 2025). Net loss: CA$2.96m (loss widened 20% from 2Q 2025). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. New Risk • Jul 17
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 47% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-CA$12m). Shareholders have been substantially diluted in the past year (47% increase in shares outstanding). Minor Risk Market cap is less than US$100m (CA$24.0m market cap, or US$17.5m). Announcement • Jul 10
PesoRama Inc. announced that it has received CAD 6.8 million in funding On July 9, 2025, PesoRama Inc. closed the transaction. Each warrant will entitle the holder thereof to acquire one Common Share (a at a price of CAD 0.30 per Warrant Share for a period of 24 months from September 7, 2025, being the date that is 60 days following
the closing date. In connection with the offering, the company paid a cash commission of CAD 334,853.04 and issued 2,232,353 non-transferable finder warrants. Announcement • Jun 10
PesoRama Inc. announced that it expects to receive CAD 5 million in funding PesoRama Inc announced a non-brokered private placement to issue 33,333,333 units of the Company at a price of CAD 0.15 per Unit for aggregate gross proceeds of CAD 4,999,999.95 on June 10, 2025. Each Unit will consist of one common share of the company and one common share purchase warrant. Each warrant will be exercisable for a period of 24 months from 60 days following the Closing Date. Insiders and certain consultants that participate in the LIFE Offering would be subject to a four-month hold period in respect of securities issued pursuant to applicable policies of the TSXV. The company will pay Markette a fee equal to 1% of the gross proceeds raised through the Platform provided by Markette ventures Inc. The company may pay eligible finders a cash fee equal to 7% of the gross proceeds of the offering from Investors introduced by such finders. The transaction is expected to close on or about June 26, 2025. Reported Earnings • Jun 03
Full year 2025 earnings released: CA$0.11 loss per share (vs CA$0.11 loss in FY 2024) Full year 2025 results: CA$0.11 loss per share (improved from CA$0.11 loss in FY 2024). Revenue: CA$23.4m (up 14% from FY 2024). Net loss: CA$10.1m (loss narrowed 4.7% from FY 2024). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 17% per year, which means it is significantly lagging earnings. New Risk • May 16
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$13.9m (US$9.93m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$5.3m free cash flow). Negative equity (-CA$5.7m). Earnings have declined by 5.8% per year over the past 5 years. Market cap is less than US$10m (CA$13.9m market cap, or US$9.93m). Minor Risk Share price has been volatile over the past 3 months (15% average weekly change). Board Change • Mar 02
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Independent Director Antonio Heredia was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. New Risk • Feb 27
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$5.3m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Negative equity (-CA$5.7m). Earnings have declined by 5.8% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CA$14.9m market cap, or US$10.3m). Reported Earnings • Dec 18
Third quarter 2025 earnings released: CA$0.018 loss per share (vs CA$0.029 loss in 3Q 2024) Third quarter 2025 results: CA$0.018 loss per share (improved from CA$0.029 loss in 3Q 2024). Revenue: CA$5.42m (up 4.1% from 3Q 2024). Net loss: CA$1.77m (loss narrowed 35% from 3Q 2024). New Risk • Nov 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$5.9m free cash flow). Negative equity (-CA$3.2m). Earnings have declined by 8.9% per year over the past 5 years. Market cap is less than US$10m (CA$11.5m market cap, or US$8.23m). Minor Risk Share price has been volatile over the past 3 months (13% average weekly change). New Risk • Sep 19
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: CA$12.5m (US$9.19m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$4.5m free cash flow). Negative equity (-CA$118k). Earnings have declined by 13% per year over the past 5 years. Market cap is less than US$10m (CA$12.5m market cap, or US$9.19m). Minor Risk Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Announcement • Jul 10
PesoRama Inc., Annual General Meeting, Aug 30, 2024 PesoRama Inc., Annual General Meeting, Aug 30, 2024. Reported Earnings • Jun 27
First quarter 2025 earnings released: CA$0.026 loss per share (vs CA$0.026 loss in 1Q 2024) First quarter 2025 results: CA$0.026 loss per share (in line with 1Q 2024). Revenue: CA$5.74m (up 29% from 1Q 2024). Net loss: CA$2.47m (loss widened 6.6% from 1Q 2024). Reported Earnings • May 23
Full year 2024 earnings released: CA$0.11 loss per share (vs CA$0.16 loss in FY 2023) Full year 2024 results: CA$0.11 loss per share (improved from CA$0.16 loss in FY 2023). Revenue: CA$20.5m (up 41% from FY 2023). Net loss: CA$10.6m (loss narrowed 11% from FY 2023). New Risk • Feb 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 13% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$3.2m free cash flow). Earnings have declined by 20% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Shareholders have been diluted in the past year (5.7% increase in shares outstanding). Market cap is less than US$100m (CA$17.7m market cap, or US$13.1m). Reported Earnings • Dec 22
Third quarter 2024 earnings released: CA$0.029 loss per share (vs CA$0.048 loss in 3Q 2023) Third quarter 2024 results: CA$0.029 loss per share (improved from CA$0.048 loss in 3Q 2023). Revenue: CA$5.21m (up 26% from 3Q 2023). Net loss: CA$2.72m (loss narrowed 23% from 3Q 2023). Announcement • Nov 26
PesoRama Inc. Announces the Appointment of Rodrigo Castan as Chief Operating Officer PesoRama Inc. announced the appointment of Rodrigo Castan as Chief Operating Officer of the Company's operating subsidiaries in Mexico City. Mr. Castan joins with vast experience in several sectors including retail, marketing and fast-moving consumer goods. Within retail he has had experience in operations, expansion, finance, and marketing, among other areas. He worked for four years in Colombia for Tiendas D1, the hard discount retailer in Latin America with over 2,300 stores, where he was responsible for expansion and opened north of 1,100 stores during that period. With Tiendas D1 he implemented an expansion booster plan, led store maintenance, relocations, remodelling, and national security, as well as being a member of the executive committee. Before joining Tiendas D1 he worked for several years for DIA Group, a Spanish food retail company with more than 7,000 stores. With DIA he held responsibilities in Spain and in China where he lived for several years in Shanghai. He covered areas such as operations, sales manager, human resources, expansion, and business controlling. He holds a Business Administration and Law Degree from Universidad Pontificia Comillas and a Master's Degree in International Business from Zhejiang University. Reported Earnings • Sep 30
Second quarter 2024 earnings released: CA$0.05 loss per share (vs CA$0.04 loss in 2Q 2023) Second quarter 2024 results: CA$0.05 loss per share (further deteriorated from CA$0.04 loss in 2Q 2023). Revenue: CA$4.49m (up 49% from 2Q 2023). Net loss: CA$4.54m (loss widened 58% from 2Q 2023). New Risk • Jun 30
New major risk - Revenue and earnings growth Earnings have declined by 29% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$4.3m free cash flow). Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 29% per year over the past 5 years. Minor Risks Shareholders have been diluted in the past year (26% increase in shares outstanding). Market cap is less than US$100m (CA$19.9m market cap, or US$15.1m). Announcement • Jun 15
PesoRama Inc., Annual General Meeting, Aug 08, 2023 PesoRama Inc., Annual General Meeting, Aug 08, 2023. Reported Earnings • Jun 02
Full year 2023 earnings released: CA$0.16 loss per share (vs CA$0.23 loss in FY 2022) Full year 2023 results: CA$0.16 loss per share. Revenue: CA$14.5m (up 55% from FY 2022). Net loss: CA$11.9m (loss widened 7.8% from FY 2022). Announcement • Jan 24
PesoRama Inc. announced that it has received CAD 2.66404 million in funding On January 23, 2023, PesoRama Inc. closed the transaction. The company has issue 11,820,931 units at an issue price of CAD 0.15 for the gross proceeds of CAD 1,773,140 in the second and final tranche. The company has paid the finder's fees of CAD 162,192.65 and aggregate of 685,365 finder warrants in connection with second and final tranche. Each Finder Warrant is exercisable into Common Shares at a price of CAD 0.15 per Common Share until January 23, 2026. All securities issued pursuant to the transaction will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation. Reported Earnings • Dec 23
Third quarter 2023 earnings released: CA$0.048 loss per share (vs CA$0.042 loss in 3Q 2022) Third quarter 2023 results: CA$0.048 loss per share (further deteriorated from CA$0.042 loss in 3Q 2022). Revenue: CA$4.13m (up 57% from 3Q 2022). Net loss: CA$3.52m (loss widened 71% from 3Q 2022). Announcement • Dec 09
PesoRama Inc. announced that it expects to receive CAD 2 million in funding PesoRama Inc. announced a non-brokered private placement of units for gross proceeds of up to CAD 2 million on December 8, 2022. The unit issue price will be determined in the market. Each unit will be comprised of one common share and one whole common share purchase warrant. Each warrant will entitle the holder thereof to acquire one common share. Closing of the offering is subject to receipt of all necessary corporate and regulatory approvals, including the approval of TSX Venture Exchange. All securities issued in connection with the offering will be subject to a hold period of four months plus a day from the date of issuance and the resale rules of applicable securities legislation. Reported Earnings • Aug 25
First quarter 2023 earnings released: CA$0.09 loss per share (vs CA$0.036 loss in 1Q 2022) First quarter 2023 results: CA$0.09 loss per share (down from CA$0.036 loss in 1Q 2022). Revenue: CA$2.25m (up 36% from 1Q 2022). Net loss: CA$6.31m (loss widened 268% from 1Q 2022). Board Change • Aug 02
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Andrew Parks was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Jun 15
PesoRama Inc. Announces Transition of Chief Financial Officer PesoRama Inc. announced that the company's Chief Financial Officer ("CFO"), Lynn Chapman, has stepped down effective June 13, 2022. Lynn was providing CFO services to the Company on a contract basis and has taken on an advisory role until June 30, 2022 to ensure a smooth transition of this office. A search to fill the CFO role is currently underway. Reported Earnings • Jun 03
Full year 2022 earnings released: CA$0.23 loss per share (vs CA$0.15 loss in FY 2021) Full year 2022 results: CA$0.23 loss per share (down from CA$0.15 loss in FY 2021). Revenue: CA$9.35m (up 107% from FY 2021). Net loss: CA$11.1m (loss widened 56% from FY 2021). Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Director Andrew Parks was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Feb 26
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Director Andrew Parks was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 